메뉴 건너뛰기




Volumn 34, Issue 1, 2006, Pages 107-114

Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

EID: 30344478848     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2005.09.013     Document Type: Article
Times cited : (12)

References (36)
  • 1
    • 0035892108 scopus 로고    scopus 로고
    • Peripheral blood stem cell vs bone marrow allotransplantation: Does the source of hematopoietic stem cells matter?
    • M. Korbling, and P. Anderlini Peripheral blood stem cell vs bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood 98 2001 2900 2908
    • (2001) Blood , vol.98 , pp. 2900-2908
    • Korbling, M.1    Anderlini, P.2
  • 2
    • 0036682921 scopus 로고    scopus 로고
    • Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia
    • N. Schmitz, M. Beksac, and D. Hasenclever Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia Blood 100 2002 761 767
    • (2002) Blood , vol.100 , pp. 761-767
    • Schmitz, N.1    Beksac, M.2    Hasenclever, D.3
  • 3
    • 18844463655 scopus 로고    scopus 로고
    • Allogeneic blood and bone marrow stem-cell transplantation in haematological malignant diseases: A randomised trial
    • R. Powles, J. Mehta, and S. Kulkarni Allogeneic blood and bone marrow stem-cell transplantation in haematological malignant diseases: a randomised trial Lancet 355 2000 1231 1237
    • (2000) Lancet , vol.355 , pp. 1231-1237
    • Powles, R.1    Mehta, J.2    Kulkarni, S.3
  • 4
    • 0034129402 scopus 로고    scopus 로고
    • A randomised study of allogeneic transplantation with stem cells from blood or bone marrow
    • D. Heldal, G. Tjonnfjord, and L. Brinch A randomised study of allogeneic transplantation with stem cells from blood or bone marrow Bone Marrow Transplant 25 2000 1129 1136
    • (2000) Bone Marrow Transplant , vol.25 , pp. 1129-1136
    • Heldal, D.1    Tjonnfjord, G.2    Brinch, L.3
  • 5
    • 0032406754 scopus 로고    scopus 로고
    • A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies
    • A.C. Vigorito, W.M. Azevedo, and J.F. Marques A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies Bone Marrow Transplant 22 1998 1145 1151
    • (1998) Bone Marrow Transplant , vol.22 , pp. 1145-1151
    • Vigorito, A.C.1    Azevedo, W.M.2    Marques, J.F.3
  • 6
    • 0036720739 scopus 로고    scopus 로고
    • A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies
    • S. Couban, D.R. Simpson, and M.J. Barnett A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies Blood 100 2002 1525 1531
    • (2002) Blood , vol.100 , pp. 1525-1531
    • Couban, S.1    Simpson, D.R.2    Barnett, M.J.3
  • 7
    • 0033971243 scopus 로고    scopus 로고
    • Randomized trial of bone marrow vs lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de Greffe de Moelle
    • D. Blaise, M. Kuentz, and C. Fortanier Randomized trial of bone marrow vs lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Francaise de Greffe de Moelle J Clin Oncol 18 2000 537 546
    • (2000) J Clin Oncol , vol.18 , pp. 537-546
    • Blaise, D.1    Kuentz, M.2    Fortanier, C.3
  • 8
    • 0035905908 scopus 로고    scopus 로고
    • Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers
    • W.I. Bensinger, P.J. Martin, and B. Storer Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers N Engl J Med 344 2001 175 181
    • (2001) N Engl J Med , vol.344 , pp. 175-181
    • Bensinger, W.I.1    Martin, P.J.2    Storer, B.3
  • 9
    • 0038189718 scopus 로고    scopus 로고
    • Bone marrow transplantation: How important is CD34 cell dose in HLA-identical stem cell transplantation?
    • S. Heimfeld Bone marrow transplantation: how important is CD34 cell dose in HLA-identical stem cell transplantation? Leukemia 17 2003 856 858
    • (2003) Leukemia , vol.17 , pp. 856-858
    • Heimfeld, S.1
  • 10
    • 0036839562 scopus 로고    scopus 로고
    • Chronic graft-vs-host disease after allogeneic blood stem cell transplantation: Long-term results of a randomized study
    • M. Mohty, M. Kuentz, and M. Michallet Chronic graft-vs-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study Blood 100 2002 3128 3134
    • (2002) Blood , vol.100 , pp. 3128-3134
    • Mohty, M.1    Kuentz, M.2    Michallet, M.3
  • 11
    • 0031454790 scopus 로고    scopus 로고
    • Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-vs-host disease
    • J. Storek, T. Gooley, and M. Siadak Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-vs-host disease Blood 90 1997 4705 4709
    • (1997) Blood , vol.90 , pp. 4705-4709
    • Storek, J.1    Gooley, T.2    Siadak, M.3
  • 12
    • 0037100280 scopus 로고    scopus 로고
    • Comparison of chronic graft-vs-host disease after transplantation of peripheral blood stem cells vs bone marrow in allogeneic recipients: Long-term follow-up of a randomized trial
    • M.E. Flowers, P.M. Parker, and L.J. Johnston Comparison of chronic graft-vs-host disease after transplantation of peripheral blood stem cells vs bone marrow in allogeneic recipients: long-term follow-up of a randomized trial Blood 100 2002 415 419
    • (2002) Blood , vol.100 , pp. 415-419
    • Flowers, M.E.1    Parker, P.M.2    Johnston, L.J.3
  • 13
    • 0038189636 scopus 로고    scopus 로고
    • + peripheral blood stem cells are associated with increased mortality from chronic graft-vs-host disease after allogeneic HLA-identical sibling transplantation
    • + peripheral blood stem cells are associated with increased mortality from chronic graft-vs-host disease after allogeneic HLA-identical sibling transplantation Leukemia 17 2003 869 875
    • (2003) Leukemia , vol.17 , pp. 869-875
    • Mohty, M.1    Bilger, K.2    Jourdan, E.3
  • 14
    • 0033566990 scopus 로고    scopus 로고
    • Risk factors for acute graft-vs-host disease after allogeneic blood stem cell transplantation
    • D. Przepiorka, T.L. Smith, and J. Folloder Risk factors for acute graft-vs-host disease after allogeneic blood stem cell transplantation Blood 94 1999 1465 1470
    • (1999) Blood , vol.94 , pp. 1465-1470
    • Przepiorka, D.1    Smith, T.L.2    Folloder, J.3
  • 15
    • 0141707823 scopus 로고    scopus 로고
    • +-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies
    • +-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies Exp Hematol 31 2003 855 864
    • (2003) Exp Hematol , vol.31 , pp. 855-864
    • Cornelissen, J.J.1    Van Der Holt, B.2    Petersen, E.J.3
  • 16
    • 0035761435 scopus 로고    scopus 로고
    • CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-vs-host disease after human leukocyte antigen-identical sibling transplantation
    • J.M. Zaucha, T. Gooley, and W.I. Bensinger CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-vs-host disease after human leukocyte antigen-identical sibling transplantation Blood 98 2001 3221 3227
    • (2001) Blood , vol.98 , pp. 3221-3227
    • Zaucha, J.M.1    Gooley, T.2    Bensinger, W.I.3
  • 17
    • 0037089391 scopus 로고    scopus 로고
    • Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation
    • H. Bittencourt, V. Rocha, and S. Chevret Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation Blood 99 2002 2726 2733
    • (2002) Blood , vol.99 , pp. 2726-2733
    • Bittencourt, H.1    Rocha, V.2    Chevret, S.3
  • 18
    • 13844320989 scopus 로고    scopus 로고
    • CD34, CD4, CD8 cell doses do not influence engraftment, graft-vs-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies
    • T.M. Cao, R.M. Wong, and K. Sheehan CD34, CD4, CD8 cell doses do not influence engraftment, graft-vs-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies Exp Hematol 33 2005 279 285
    • (2005) Exp Hematol , vol.33 , pp. 279-285
    • Cao, T.M.1    Wong, R.M.2    Sheehan, K.3
  • 19
    • 0033575383 scopus 로고    scopus 로고
    • Prevention of graft vs host disease by inactivation of host antigen-presenting cells
    • W.D. Shlomchik, M.S. Couzens, and C.B. Tang Prevention of graft vs host disease by inactivation of host antigen-presenting cells Science 285 1999 412 415
    • (1999) Science , vol.285 , pp. 412-415
    • Shlomchik, W.D.1    Couzens, M.S.2    Tang, C.B.3
  • 21
    • 0027497576 scopus 로고
    • Acute graft-vs-host disease prophylaxis with methotrexate and cyclosporine after busulfan and cyclophosphamide in patients with hematologic malignancies
    • A. Von Bueltzingsloewen, R. Belanger, and C. Perreault Acute graft-vs-host disease prophylaxis with methotrexate and cyclosporine after busulfan and cyclophosphamide in patients with hematologic malignancies Blood 81 1993 849 855
    • (1993) Blood , vol.81 , pp. 849-855
    • Von Bueltzingsloewen, A.1    Belanger, R.2    Perreault, C.3
  • 25
    • 0345700849 scopus 로고    scopus 로고
    • Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim
    • V. Moncada, C. Bolan, Y. Yau, and S. Leitman Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim Transfusion 43 2003 495 501
    • (2003) Transfusion , vol.43 , pp. 495-501
    • Moncada, V.1    Bolan, C.2    Yau, Y.3    Leitman, S.4
  • 27
    • 13244284668 scopus 로고    scopus 로고
    • Impact of CD34 subsets on engraftment kinetics in allogeneic peripheral blood stem cell transplantation
    • A.M. Kamel, N. El-Sharkawy, and H.K. Mahmoud Impact of CD34 subsets on engraftment kinetics in allogeneic peripheral blood stem cell transplantation Bone Marrow Transplant 35 2005 129 136
    • (2005) Bone Marrow Transplant , vol.35 , pp. 129-136
    • Kamel, A.M.1    El-Sharkawy, N.2    Mahmoud, H.K.3
  • 28
    • 0042744732 scopus 로고    scopus 로고
    • + cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation
    • + cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation Blood 102 2003 1108 1113
    • (2003) Blood , vol.102 , pp. 1108-1113
    • Perez-Simon, J.A.1    Diez-Campelo, M.2    Martino, R.3
  • 29
    • 19944430997 scopus 로고    scopus 로고
    • + cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation
    • + cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation Leuk Lymphoma 56 2005 177 183
    • (2005) Leuk Lymphoma , vol.56 , pp. 177-183
    • Diez-Campelo, M.1    Perez-Simon, J.A.2    Ocio, E.M.3
  • 30
    • 0029592212 scopus 로고
    • Risk factors for acute graft-vs-host disease in 291 consecutive HLA-identical bone marrow transplant recipients
    • H. Hagglund, L. Bostrom, M. Remberger, P. Ljungman, B. Nilsson, and O. Ringden Risk factors for acute graft-vs-host disease in 291 consecutive HLA-identical bone marrow transplant recipients Bone Marrow Transplant 16 1995 747 753
    • (1995) Bone Marrow Transplant , vol.16 , pp. 747-753
    • Hagglund, H.1    Bostrom, L.2    Remberger, M.3    Ljungman, P.4    Nilsson, B.5    Ringden, O.6
  • 31
    • 0026779259 scopus 로고
    • Acute graft-vs-host disease: Analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate
    • R.A. Nash, M.S. Pepe, and R. Storb Acute graft-vs-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate Blood 80 1992 1838 1845
    • (1992) Blood , vol.80 , pp. 1838-1845
    • Nash, R.A.1    Pepe, M.S.2    Storb, R.3
  • 32
    • 0021268573 scopus 로고
    • Predictive factors for acute graft-vs-host disease in patients transplanted with HLA-identical bone marrow
    • D.S. Bross, P.J. Tutschka, and E.R. Farmer Predictive factors for acute graft-vs-host disease in patients transplanted with HLA-identical bone marrow Blood 63 1984 1265 1270
    • (1984) Blood , vol.63 , pp. 1265-1270
    • Bross, D.S.1    Tutschka, P.J.2    Farmer, E.R.3
  • 33
    • 0034760116 scopus 로고    scopus 로고
    • Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplants
    • V. Rocha, M.V. Carmagnat, and S. Chevret Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplants Exp Hematol 29 2001 1347 1352
    • (2001) Exp Hematol , vol.29 , pp. 1347-1352
    • Rocha, V.1    Carmagnat, M.V.2    Chevret, S.3
  • 34
    • 0032525102 scopus 로고    scopus 로고
    • + cells identifies immunocompetent committed precursors of macrophages and dendritic cells
    • + cells identifies immunocompetent committed precursors of macrophages and dendritic cells Blood 91 1998 3892 3900
    • (1998) Blood , vol.91 , pp. 3892-3900
    • Ryncarz, R.E.1    Anasetti, C.2
  • 36
    • 4644269742 scopus 로고    scopus 로고
    • Donor APCs are required for maximal GVHD but not for GVL
    • C.C. Matte, J. Liu, and J. Cormier Donor APCs are required for maximal GVHD but not for GVL Nat Med 10 2004 987 992
    • (2004) Nat Med , vol.10 , pp. 987-992
    • Matte, C.C.1    Liu, J.2    Cormier, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.